Retatrutide Protocol: Concentrations Behind the Schedule
A retatrutide protocol is unusually easy to write, because a real trial dose exists. This page runs the vial arithmetic and refuses to run that conversion.
MEDICAL DISCLAIMER: Educational research guidelines only. Lyophilized peptides are investigational chemical compounds and are NOT approved for human consumption, diagnosis, or therapy. Consult a licensed physician before any research application.
A retatrutide protocol is easier to write than any other on this site, and that is precisely the problem. Every other compound covered here lacks a published human figure, so the arithmetic has nothing to aim at and the refusal to name an amount is almost automatic. Here a real trial dose exists, in a real journal, attached to a real result. One division separates a concentration from a volume that matches it.
This page does not perform that division. The reason is that no regulator anywhere has approved this compound, so the arrangement that produced the trial figure, a verified product administered under supervision to a selected population, cannot be reconstructed by anyone working from a research vial. The number survives the move and none of its conditions do. What follows is the full laboratory handling arithmetic, worked in detail, followed by an explicit account of where it stops and why the existence of a genuine trial number makes the stopping point more important rather than less.
Lowest cost per milligram we track
Retatrutide — Ascension Peptides
Independently assayed research material. With the code the 30 mg works out at $3.33/mg and the 10 mg at $4.00/mg.
The certificate that resolves for this compound is MZ Biolabs lot 03-01260229, reporting 99.94 percent purity and 11.67 mg against a 10 mg label, purity and quantity only, with no endotoxin or sterility screen. A second certificate is linked on the product page and does not load. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- One third-party assay per batch
- Free carriage over $250
- Same-day dispatch before 2pm CST
Laboratory research material only, not for human consumption. Affiliate links: we may earn a commission at no additional cost to you. Figures checked September 9, 2026.
A retatrutide protocol posted online and the document it borrows from
The word protocol is doing two jobs. In the Phase 2 work published in the New England Journal of Medicine in 2023 by Jastreboff and colleagues, a protocol was the full study design. On a forum it is a paragraph. Setting the elements side by side shows which parts a reader could ever supply.
| Element | In the published trial | In a forum protocol | Can a buyer supply it? |
|---|---|---|---|
| Product of verified content | Yes | No | No, not without an independent assay |
| Entry criteria for who receives it | Yes | No | No |
| Supervised escalation to the assigned amount | Yes | Sometimes imitated in text | No, imitation is not supervision |
| Monitoring during the period | Yes | No | No |
| A comparison group | Yes | No | No |
| Defined follow up to a stated endpoint | Yes, to 48 weeks | No | No |
| A stated concentration in mg per mL | Not applicable, the product was manufactured | Occasionally | Yes |
| A stated syringe scale | Not applicable | Rarely | Yes |
The inversion in the last two rows is the interesting part. The two fields a reader can genuinely supply are the two the trial had no need to publish, because its product arrived ready. The six fields that gave the trial result its meaning are all in the column a buyer cannot fill. A forum protocol copies the shape of the document and none of the load bearing parts.
The conversion machinery, stated without a target
Concentration is labelled mass divided by diluent volume, and everything downstream is that ratio applied twice. The masses below are arbitrary reference figures chosen because they are round numbers that expose rounding behaviour on a barrel. They are not amounts, not suggestions, and not derived from anything in the trial.
| Diluent added to a 10 mg vial | Concentration | Mass in one U-100 unit | Units holding 0.25 mg | Units holding 0.5 mg | Falls on a graduation? |
|---|---|---|---|---|---|
| 1 mL | 10 mg per mL | 100 mcg | 2.5 | 5 | Only the second |
| 2 mL | 5 mg per mL | 50 mcg | 5 | 10 | Both |
| 2.5 mL | 4 mg per mL | 40 mcg | 6.25 | 12.5 | Neither |
| 4 mL | 2.5 mg per mL | 25 mcg | 10 | 20 | Both |
The third row is the one worth studying. A fill volume of 2.5 mL is a perfectly sensible looking number that produces a concentration on which round masses land between graduations. Six and a quarter units is not a mark on a barrel, so the figure gets rounded or estimated by eye, and neither of those is a measurement. The defect is created upstream by the choice of diluent volume, and it is fixed upstream by choosing a fill volume that puts the masses of interest on whole units.
That is a bench decision made with a calculator before anything is opened. It has no biological content whatever, which is why it can be discussed here in full.
Residual volume strands a fraction that depends on the fill
A vial is never emptied completely. Assume 0.05 mL cannot be recovered from the bottom, stated as an assumed input rather than as a measured property of any container. The mass that assumption strands depends entirely on the concentration.
At 1 mL of diluent the concentration is 10 mg per mL, so 0.05 mL holds 0.5 mg, one twentieth of the vial. At 2 mL the concentration is 5 mg per mL, so the same residual volume holds 0.25 mg, one fortieth. At 4 mL it holds 0.125 mg, one eightieth.
The pattern runs against instinct. A tight fill volume feels economical, and it strands four times as much material as a generous one because the unrecoverable liquid is more concentrated. This sits alongside the graduation argument and pushes in the same direction, which is a rare piece of luck: larger fill volumes give finer relative reading precision and lose less material, up to the point where a draw no longer fits inside one barrel.
Diluent measurement error, in the direction that matters
The diluent is usually measured with a syringe, and a small error there rewrites every figure derived afterwards.
Intending 2 mL on a 10 mg vial and adding 1.9 mL gives 10 divided by 1.9, about 5.26 mg per mL rather than 5. Every draw then carries roughly one part in nineteen more mass than the calculation says, and the syringe reports the volume correctly throughout, because volume is the thing that was measured properly. Overshooting to 2.1 mL gives 4.76 mg per mL and the same size of error the other way.
Under adding is the direction worth flagging on a compound handled in fractions of a milligram, since it makes every subsequent figure an underestimate of what is actually drawn. Neither error is visible. The only protection is measuring the diluent with an appropriately sized syringe in a single transfer and writing the volume down at the moment it goes in.
Why no amount appears anywhere above
No figure on this page is a recommended amount for a person, and the trial dose is not converted into a volume or a unit reading. That refusal needs a reason, and it has four.
The compound is unapproved in every market. No regulator has completed a review, so there is no assessed label, no assessed dosing section, and no prescription route. The absence is not an oversight in this article; it is the actual state of the world.
The published trial figure is a property of an arrangement, not of a molecule. It was reached by supervised escalation, in participants who met entry criteria, using a product of verified content, with monitoring and a comparison group, followed to a defined endpoint. Reproducing the arithmetic reproduces one digit and none of that.
The numerator would be unverified. Every calculation above starts from a labelled mass, which for a research chemical is a seller's claim rather than an assay result. A confident volume derived from an unchecked mass is confident about the wrong thing.
And division has no access to the variables that would matter. It converts between mass, volume and graduations, correctly and completely. It cannot represent escalation, tolerability, monitoring or an endpoint, so it cannot produce an amount even in principle. The existence of a real trial number does not change that. It only makes the wrong calculation feel more legitimate, which is the specific hazard this page exists to name.
Frequently Asked Questions
Does a real published dose make a home protocol more defensible?expand_more
No. It makes one number in the protocol real and leaves every other field empty. The trial figure was reached under conditions none of which a buyer can supply, so importing it imports a digit and discards the design.
Which fill volume in the table should be used?expand_more
That depends on the masses being measured, and this page does not name any. The general rule the arithmetic supports is that a fill volume should put the masses of interest on whole graduations and keep the draw inside one barrel.
Why does a larger fill volume waste less material?expand_more
Because the unrecoverable residue at the bottom of the vial is a volume, not a mass. Diluting the same labelled mass into more liquid means that fixed residual volume holds proportionally less compound.
If the diluent volume was guessed, can the concentration be recovered?expand_more
Not by inspection. A solution looks the same at any concentration, and the label only ever stated a mass. Without a recorded fill volume every derived figure from that vial is unverifiable.
Is there an approved product that could be used as a reference instead?expand_more
Not for this compound. There is no marketing authorisation anywhere, so no assessed label exists to compare against, which is exactly why the published trial gets used as a stand in and why that substitution fails.
What would have to change for a page like this to name an amount?expand_more
A completed regulatory review producing an approved product with an assessed label, dispensed through a pharmacy, with manufacturing oversight behind the mass on the container. At that point the amount would come from the label and not from arithmetic on a research vial.